Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ALBT
stocks logo

ALBT

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Valuation Metrics

The current forward P/E ratio for Avalon Globocare Corp (ALBT.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Avalon Globocare Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

ALBT News & Events

Events Timeline

(ET)
2025-12-01
09:10:00
Avalon Launches Holistic Health Reset Program with First Responders in Nevada
select
2025-07-28 (ET)
2025-07-28
09:05:34
Avalon enters distribution agreement with Saga Health for KetoAir
select
2025-07-14 (ET)
2025-07-14
08:07:13
Avalon announces patent issuance for CAR-T, CAR-NK tech in Hong Kong
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
3.5
12-01Globenewswire
Avalon Launches KetoAir™ Breathalyzer, Expands into International Markets
  • Program Launch: In August 2025, Avalon, in collaboration with Saga Health and SpecialtyHealth, initiated the four-month “Nevada POOL/PACT Holistic Health Reset” program for 50 first responders, utilizing KetoAir™ for continuous monitoring of metabolic changes to enhance participants' health outcomes.
  • International Expansion: On September 1, 2025, Avalon launched its FDA-registered KetoAir™ breathalyzer for sale in the UK, marking its first international market entry, which is expected to increase the company's market share amid rising global demand for metabolic health tools.
  • Product Showcase: Avalon presented KetoAir™ at the London Health Optimization Summit on September 13-14, 2025, where attendees learned about its integration into broader wellness programs, thereby enhancing brand visibility and engagement.
  • Health Improvement: Mid-program data from October indicates that first responders in Nevada experienced health improvements, with KetoAir™ serving as a measurement tool to help participants track daily ketone levels, thereby promoting healthier lifestyle choices.
[object Object]
Preview
3.5
12-01Newsfilter
Avalon GloboCare Launches KetoAir™ Breathalyzer and Expands Market Reach
  • Health Program Launch: Avalon, in collaboration with Saga Health and SpecialtyHealth, initiated a four-month 'Holistic Health Reset' program for 50 first responders in Nevada, aiming to enhance metabolic, physical, and behavioral health through continuous monitoring with KetoAir™.
  • International Market Expansion: On September 1, 2025, Avalon launched its FDA-registered KetoAir™ breathalyzer in the UK, marking its first international market entry, which is expected to increase the company's market share amid rising global demand for metabolic health tools.
  • Product Showcase Event: Avalon showcased KetoAir™ at the London Health Optimization Summit on September 13-14, 2025, allowing attendees to learn how the product integrates into broader wellness programs, thereby enhancing brand visibility and market acceptance.
  • Mid-Program Results Feedback: Mid-program data from the Nevada health reset initiative indicate individual improvements in metabolic health, with KetoAir™ serving as a measurement and accountability tool that helps participants track daily ketone levels, thereby increasing the likelihood of achieving their health goals.
[object Object]
Preview
7.5
06-26NASDAQ.COM
Avalon GloboCare Corp. Partners with Qi Diagnostics to Develop Cannabis Breathalyzer Technology

  • Partnership Announcement: Avalon GloboCare has partnered with Qi Diagnostics to co-develop a cannabis breathalyzer that utilizes VOC nanosensor technology for real-time detection of cannabis impairment, aimed at enhancing public safety and supporting law enforcement.

  • Current Products and Future Plans: Avalon is also marketing the KetoAir breathalyzer as an FDA-registered Class I medical device and is pursuing further advancements in its diagnostic technology portfolio, including a proposed merger with YOOV Group Holding Limited.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Avalon Globocare Corp (ALBT) stock price today?

The current price of ALBT is 1.46 USD — it has increased 12.31 % in the last trading day.

arrow icon

What is Avalon Globocare Corp (ALBT)'s business?

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.

arrow icon

What is the price predicton of ALBT Stock?

Wall Street analysts forecast ALBT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALBT is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Avalon Globocare Corp (ALBT)'s revenue for the last quarter?

Avalon Globocare Corp revenue for the last quarter amounts to 350.10K USD, increased 1.43 % YoY.

arrow icon

What is Avalon Globocare Corp (ALBT)'s earnings per share (EPS) for the last quarter?

Avalon Globocare Corp. EPS for the last quarter amounts to -0.06 USD, decreased -96.70 % YoY.

arrow icon

What changes have occurred in the market's expectations for Avalon Globocare Corp (ALBT)'s fundamentals?

The market is revising No Change the revenue expectations for ALBT for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -37.07%.
arrow icon

How many employees does Avalon Globocare Corp (ALBT). have?

Avalon Globocare Corp (ALBT) has 5 emplpoyees as of December 05 2025.

arrow icon

What is Avalon Globocare Corp (ALBT) market cap?

Today ALBT has the market capitalization of 6.13M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free